AUGMENTIN
National Drug Authority (NDA) during routine monitoring, surveillance and intelligence on the quality of medical products on the market discovered a substandard and falsified medicine, AugmentinTM (Amoxicillin/Clavulanic Acid) Batch 786627 purported to be manufactured by GSK. Augmentin is a broad spectrum antibiotic used in the management of infections including Lower and upper respiratory infection and genital urinary tract infections among others.
| Brand Name | Batch | Purported Manufacturer | Date of manufacture | Date of expiry |
|---|---|---|---|---|
| AUGMENTIN | 786627 | GSK | AUG 2016 | AUG 2019 |
NDA carried out surveillance in over 500 suspected drug outlets across the country and impounded the product from 14 drug outlets where investigations with the Manufacturer are ongoing for the source of the product.
It was established that this same product was discovered in Kenya and recently has been distributed in Uganda.
POSTINOR-2
The market surveillance discovered a substandard/falsified postinor-2 (Levonogestrel) with different particulars on the secondary and primary package. Postinor-2 is an oral emergency contraceptive pill used to prevent pregnancy after having unprotected sex.
| DETAILS ON THE SECONDARY PACKAGE; | DETAILS ON THE PRIMARY PACKAGE; |
|---|---|
| Batch no. T71708E | Batch no. T73261 |
| Mfg. date: 01/2017 | Mfg. date: 03/2017 |
| Exp. date: 01/2022 | Exp. date: 03/2022 |
This product was impounded from all drug outlets across the country where it was found and the suspect was arrested and investigations are on-going with Police. There is an ongoing case in court.
QUININE BISULPHATE
NDA market surveillance and intelligence discovered substandard/falsified Quinine Bisulphate tablets containing metronidazole. It was found with one of the suspects who was arrested during the night operation that were held on 17th April 2019. All our inspectors in the regions were alerted on this product and surveillance is ongoing.
| Brand Name | Batch | Purported Manufacturer | Date of manufacture | Date of expiry |
|---|---|---|---|---|
| QUININE BISULPHATE | 7422 | LABORATORY & ALLIED LTD | MAR 2017 | APR 2021 |
All suspects will be handled as per the NDA regulations and NDP/Act Cap 206, Section 30 on supply of impure drugs prohibits sale of any drug which is unwholesome or adulterated or which does not conform to the prescription under which it is supplied.
The public is expected to remain vigilant and report any suspected substandard products to NDA or by email to druginfo@nda.or.ug. You can also call on 0414-255665 or by sending a message on WhatsApp to 0791415555.
